Toll Free: 1-888-928-9744
Published: Feb, 2016 | Pages:
200 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Post-Operative Pain - Pipeline Review, H1 2016 Summary
Global Markets Direct's, 'Post-Operative Pain - Pipeline Review, H1 2016', provides an overview of the Post-Operative Pain pipeline landscape. The report provides comprehensive information on the therapeutics under development for Post-Operative Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the global therapeutic landscape of Post-Operative Pain - The report reviews pipeline therapeutics for Post-Operative Pain by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Post-Operative Pain therapeutics and enlists all their major and minor projects - The report assesses Post-Operative Pain therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Post-Operative Pain Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Post-Operative Pain - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Post-Operative Pain pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents
Table of Contents 2 List of Tables 6 List of Figures 7 Introduction 8 Global Markets Direct Report Coverage 8 Post-Operative Pain Overview 9 Therapeutics Development 10 Pipeline Products for Post-Operative Pain - Overview 10 Pipeline Products for Post-Operative Pain - Comparative Analysis 11 Post-Operative Pain - Therapeutics under Development by Companies 12 Post-Operative Pain - Pipeline Products Glance 16 Late Stage Products 16 Clinical Stage Products 17 Early Stage Products 18 Unknown Stage Products 19 Post-Operative Pain - Products under Development by Companies 20 Post-Operative Pain - Companies Involved in Therapeutics Development 24 A. Menarini Industrie Farmaceutiche Riunite Srl 24 AcelRx Pharmaceuticals, Inc. 25 Adynxx, Inc. 26 Amorsa Therapeutics Inc. 27 AngioChem Inc. 28 AskAt Inc. 29 Boehringer Ingelheim GmbH 30 Cara Therapeutics, Inc. 31 Chong Kun Dang Pharmaceutical Corp. 32 Colby Pharmaceutical Company 33 Cytogel Pharma, LLC 34 DURECT Corporation 35 Echo Pharmaceuticals B.V. 36 Envisia Therapeutics Inc. 37 Flexion Therapeutics, Inc. 38 Fujimoto Pharmaceutical Corporation 39 Galleon Pharmaceuticals 40 Grunenthal GmbH 41 GW Pharmaceuticals Plc 42 Heron Therapeutics, Inc. 43 Immupharma Plc 44 INSYS Therapeutics, Inc. 45 Laboratorios Del Dr. Esteve S.A. 46 Lipocure Ltd. 47 Liquidia Technologies, Inc. 48 Medtronic plc 49 Navigen Pharmaceuticals, Inc. 50 Orbis Biosciences, Inc. 51 Orion Oyj 52 PainReform Ltd. 53 Pharmazz, Inc. 54 PhytoHealth Corporation 55 Proteus SA 56 Recro Pharma, Inc. 57 Relmada Therapeutics, Inc. 58 Serina Therapeutics, Inc. 59 SteadyMed Therapeutics, Inc. 60 Takeda Pharmaceutical Company Limited 61 The Medicines Company 62 Trevena, Inc. 63 Post-Operative Pain - Therapeutics Assessment 64 Assessment by Monotherapy Products 64 Assessment by Combination Products 65 Assessment by Target 66 Assessment by Mechanism of Action 69 Assessment by Route of Administration 72 Assessment by Molecule Type 74 Drug Profiles 76 (bupivacaine hydrochloride + meloxicam) - Drug Profile 76 (dexketoprofen + tramadol hydrochloride) - Drug Profile 77 AM-4 - Drug Profile 78 AMS-410 ER12 - Drug Profile 79 ANG-2002 - Drug Profile 80 ARX-04 - Drug Profile 81 AYX-1 - Drug Profile 83 BI-1026706 - Drug Profile 84 bupivacaine ER - Drug Profile 85 bupivacaine hydrochloride - Drug Profile 86 bupivacaine hydrochloride - Drug Profile 87 bupivacaine hydrochloride SR - Drug Profile 89 buprenorphine hydrochloride - Drug Profile 92 CKD-943 - Drug Profile 93 CPC-123 - Drug Profile 94 CR-845 - Drug Profile 95 Cyt-1010 - Drug Profile 98 dexmedetomidine hydrochloride - Drug Profile 100 difluprednate XR - Drug Profile 102 dronabinol - Drug Profile 103 Drug for Post Operative Pain - Drug Profile 105 E-52862 - Drug Profile 106 ECP-1014 - Drug Profile 108 fadolmidine hydrochloride - Drug Profile 109 fentanyl - Drug Profile 111 FX-007 - Drug Profile 112 GAL-044 - Drug Profile 113 grapiprant - Drug Profile 114 IPP-102199 - Drug Profile 116 ketamine hydrochloride - Drug Profile 117 ketamine hydrochloride ER - Drug Profile 119 ketorolac tromethamine - Drug Profile 120 levorphanol tartrate ER - Drug Profile 121 MDT-10013 - Drug Profile 123 meloxicam - Drug Profile 124 meloxicam ER - Drug Profile 125 nabiximols - Drug Profile 126 nalbuphine hydrochloride - Drug Profile 129 neosaxitoxin - Drug Profile 130 oliceridine - Drug Profile 132 PMZ-2010 - Drug Profile 134 RBM-004 - Drug Profile 136 ropivacaine - Drug Profile 137 ropivacaine ER - Drug Profile 138 SER-226 - Drug Profile 139 sufentanil citrate - Drug Profile 140 Synthetic Peptides for Pain - Drug Profile 143 tapentadol hydrochloride IR - Drug Profile 144 tramadol hydrochloride - Drug Profile 146 tramadol hydrochloride ER - Drug Profile 147 URB-937 - Drug Profile 148 VVZ-149 - Drug Profile 149 Post-Operative Pain - Recent Pipeline Updates 150 Post-Operative Pain - Dormant Projects 182 Post-Operative Pain - Discontinued Products 187 Post-Operative Pain - Product Development Milestones 188 Featured News & Press Releases 188 Appendix 196 Methodology 196 Coverage 196 Secondary Research 196 Primary Research 196 Expert Panel Validation 196 Contact Us 196 Disclaimer 197
List of Tables
Number of Products under Development for Post-Operative Pain, H1 2016 13 Number of Products under Development for Post-Operative Pain - Comparative Analysis, H1 2016 14 Number of Products under Development by Companies, H1 2016 16 Number of Products under Development by Companies, H1 2016 (Contd..1) 17 Number of Products under Development by Companies, H1 2016 (Contd..2) 18 Comparative Analysis by Late Stage Development, H1 2016 19 Comparative Analysis by Clinical Stage Development, H1 2016 20 Comparative Analysis by Early Stage Development, H1 2016 21 Comparative Analysis by Unknown Stage Development, H1 2016 22 Products under Development by Companies, H1 2016 23 Products under Development by Companies, H1 2016 (Contd..1) 24 Products under Development by Companies, H1 2016 (Contd..2) 25 Products under Development by Companies, H1 2016 (Contd..3) 26 Post-Operative Pain - Pipeline by A. Menarini Industrie Farmaceutiche Riunite Srl, H1 2016 27 Post-Operative Pain - Pipeline by AcelRx Pharmaceuticals, Inc., H1 2016 28 Post-Operative Pain - Pipeline by Adynxx, Inc., H1 2016 29 Post-Operative Pain - Pipeline by Amorsa Therapeutics Inc., H1 2016 30 Post-Operative Pain - Pipeline by AngioChem Inc., H1 2016 31 Post-Operative Pain - Pipeline by AskAt Inc., H1 2016 32 Post-Operative Pain - Pipeline by Boehringer Ingelheim GmbH, H1 2016 33 Post-Operative Pain - Pipeline by Cara Therapeutics, Inc., H1 2016 34 Post-Operative Pain - Pipeline by Chong Kun Dang Pharmaceutical Corp., H1 2016 35 Post-Operative Pain - Pipeline by Colby Pharmaceutical Company, H1 2016 36 Post-Operative Pain - Pipeline by Cytogel Pharma, LLC, H1 2016 37 Post-Operative Pain - Pipeline by DURECT Corporation, H1 2016 38 Post-Operative Pain - Pipeline by Echo Pharmaceuticals B.V., H1 2016 39 Post-Operative Pain - Pipeline by Envisia Therapeutics Inc., H1 2016 40 Post-Operative Pain - Pipeline by Flexion Therapeutics, Inc., H1 2016 41 Post-Operative Pain - Pipeline by Fujimoto Pharmaceutical Corporation, H1 2016 42 Post-Operative Pain - Pipeline by Galleon Pharmaceuticals, H1 2016 43 Post-Operative Pain - Pipeline by Grunenthal GmbH, H1 2016 44 Post-Operative Pain - Pipeline by GW Pharmaceuticals Plc, H1 2016 45 Post-Operative Pain - Pipeline by Heron Therapeutics, Inc., H1 2016 46 Post-Operative Pain - Pipeline by Immupharma Plc, H1 2016 47 Post-Operative Pain - Pipeline by INSYS Therapeutics, Inc., H1 2016 48 Post-Operative Pain - Pipeline by Laboratorios Del Dr. Esteve S.A., H1 2016 49 Post-Operative Pain - Pipeline by Lipocure Ltd., H1 2016 50 Post-Operative Pain - Pipeline by Liquidia Technologies, Inc., H1 2016 51 Post-Operative Pain - Pipeline by Medtronic plc, H1 2016 52 Post-Operative Pain - Pipeline by Navigen Pharmaceuticals, Inc., H1 2016 53 Post-Operative Pain - Pipeline by Orbis Biosciences, Inc., H1 2016 54 Post-Operative Pain - Pipeline by Orion Oyj, H1 2016 55 Post-Operative Pain - Pipeline by PainReform Ltd., H1 2016 56 Post-Operative Pain - Pipeline by Pharmazz, Inc., H1 2016 57 Post-Operative Pain - Pipeline by PhytoHealth Corporation, H1 2016 58 Post-Operative Pain - Pipeline by Proteus SA, H1 2016 59 Post-Operative Pain - Pipeline by Recro Pharma, Inc., H1 2016 60 Post-Operative Pain - Pipeline by Relmada Therapeutics, Inc., H1 2016 61 Post-Operative Pain - Pipeline by Serina Therapeutics, Inc., H1 2016 62 Post-Operative Pain - Pipeline by SteadyMed Therapeutics, Inc., H1 2016 63 Post-Operative Pain - Pipeline by Takeda Pharmaceutical Company Limited, H1 2016 64 Post-Operative Pain - Pipeline by The Medicines Company, H1 2016 65 Post-Operative Pain - Pipeline by Trevena, Inc., H1 2016 66 Assessment by Monotherapy Products, H1 2016 67 Assessment by Combination Products, H1 2016 68 Number of Products by Stage and Target, H1 2016 70 Number of Products by Stage and Mechanism of Action, H1 2016 73 Number of Products by Stage and Route of Administration, H1 2016 76 Number of Products by Stage and Molecule Type, H1 2016 78 Post-Operative Pain Therapeutics - Recent Pipeline Updates, H1 2016 153 Post-Operative Pain - Dormant Projects, H1 2016 185 Post-Operative Pain - Dormant Projects (Contd..1), H1 2016 186 Post-Operative Pain - Dormant Projects (Contd..2), H1 2016 187 Post-Operative Pain - Dormant Projects (Contd..3), H1 2016 188 Post-Operative Pain - Dormant Projects (Contd..4), H1 2016 189 Post-Operative Pain - Discontinued Products, H1 2016 190
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.